PET, PET/ CT, and PET/ MR Imaging Assessment of Breast Cancer

被引：6

作者：

Shamim, Shamim Ahmed ^{[1
]}

Torigian, Drew A. ^{[2
]}

Kumar, Rakesh ^{[1
]}

机构：

[1] All India Inst Med Sci, Dept Nucl Med, E-81 Ansari Nagar East,AIIMS Campus, New Delhi 110029, India

[2] Hosp Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA

来源：

PET CLINICS | 2008年 / 3卷 / 03期

关键词：

Breast cancer; Oncology; Positron emission tomography (PET); Computed tomography (CT); Magnetic resonance imaging (MRI); PET/CT; PET/MRI; PET mammography;

D O I：

10.1016/j.cpet.2009.01.001

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

This review focuses mainly on clinical applications of PET/CT in patients with breast cancer. It discusses the role of 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) PET/CT (and FDG PET) in the diagnosis and initial staging of breast cancer, in monitoring the response of disease to chemotherapy, and in identifying metastatic and recurrent disease. In addition, it discusses the role of MR imaging and potential future hybrid modalities such as PET/MR imaging.

引用

页码：381 / +

页数：14

共 80 条

[1] EVALUATION OF BREAST MASSES AND AXILLARY LYMPH-NODES WITH [F-18] 2-DEOXY-2-FLUORO-D-GLUCOSE PET [J].

ADLER, LP ;

CROWE, JP ;

ALKAISI, NK ;

SUNSHINE, JL .

RADIOLOGY, 1993, 187 (03) :743-750

[2] Lymphatic mapping and sentinel node biopsy in the patient with breast cancer [J].

Albertini, JJ ;

Lyman, GH ;

Cox, C ;

Yeatman, T ;

Balducci, L ;

Ku, NN ;

Shivers, S ;

Berman, C ;

Wells, K ;

Rapaport, D ;

Shons, A ;

Horton, J ;

Greenberg, H ;

Nicosia, S ;

Clark, R ;

Cantor, A ;

Reintgen, DS .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (22) :1818-1822

[3] Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose [J].

Avril, N ;

Dose, J ;

Janicke, F ;

Bense, S ;

Ziegler, S ;

Laubenbacher, C ;

Romer, W ;

Pache, H ;

Herz, M ;

Allgayer, B ;

Nathrath, W ;

Graeff, H ;

Schwaiger, M .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (06) :1848-1857

[4] Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)fluoro-2-deoxy-D-glucose [J].

Avril, N ;

Dose, J ;

Janicke, F ;

Ziegler, S ;

Romer, W ;

Weber, W ;

Herz, M ;

Nathrath, W ;

Graeff, H ;

Schwaiger, M .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (17) :1204-1209

[5]

Avril Norbert, 1999, Clin Positron Imaging, V2, P261, DOI 10.1016/S1095-0397(99)00032-1

[6]

Bassa P, 1996, J NUCL MED, V37, P931

[7] Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC) [J].

Bellon, JR ;

Livingston, RB ;

Eubank, WB ;

Gralow, JR ;

Ellis, GK ;

Dunnwald, LK ;

Mankoff, DA .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (04) :407-410

[8] ANALYSIS OF CANCERS MISSED AT SCREENING MAMMOGRAPHY [J].

BIRD, RE ;

WALLACE, TW ;

YANKASKAS, BC .

RADIOLOGY, 1992, 184 (03) :613-617

[9] Magnetic resonance imaging of the breast prior to biopsy [J].

Bluemke, DA ;

Gatsonis, CA ;

Chen, MH ;

DeAngelis, GA ;

DeBruhl, N ;

Harms, S ;

Heywang-Köbrunner, SH ;

Hylton, N ;

Kuhl, CK ;

Lehman, C ;

Pisano, ED ;

Causer, P ;

Schnitt, SJ ;

Smazal, SF ;

Stelling, CB ;

Weatherall, PT ;

Schnall, MD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (22) :2735-2742

[10] PRIMARY CHEMOTHERAPY IN SURGICALLY RESECTABLE BREAST-CANCER [J].

BONADONNA, G ;

VALAGUSSA, P ;

ZUCALI, R ;

SALVADORI, B .

CA-A CANCER JOURNAL FOR CLINICIANS, 1995, 45 (04) :227-243

← 1 2 3 4 5 6 7 8 →